MeiraGTx Holdings (MGTX) Other Non-Current Liabilities (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Other Non-Current Liabilities of $1.4 million for Q4 2025, up 2.49% on a QoQ basis from $1.4 million in Q3 2025, and down 50.41% year-over-year from $2.8 million in Q4 2024.
MeiraGTx Holdings (MGTX) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- Quarterly Other Non-Current Liabilities fell 50.41% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 50.41% YoY) and the FY2025 annual result came in at $1.4 million, down 50.41% from the prior year.
- Other Non-Current Liabilities was $1.4 million for Q4 2025 at MeiraGTx Holdings, up from $1.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.9 million in Q3 2024 and bottomed at $1.3 million in Q1 2025.
- A 5-year average of $2.1 million and a median of $2.1 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities climbed 24.19% — and 2025, when it tumbled 52.6%.
- MeiraGTx Holdings' Other Non-Current Liabilities stood at $2.1 million in 2021, then rose by 4.71% to $2.2 million in 2022, then grew by 10.19% to $2.4 million in 2023, then gained by 17.49% to $2.8 million in 2024, then slumped by 50.41% to $1.4 million in 2025.
- Business Quant data shows MGTX's Other Non-Current Liabilities at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 2.30 Mn |
| Mar 31, 2023 | 2.24 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Sep 30, 2021 | 1.92 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 1.86 Mn |